Compare
Johnson & Johnson vs Prestige Consumer Healthcare (JNJ vs PBH)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Johnson & Johnson (JNJ) returned +48.5% and Prestige Consumer Healthcare (PBH) -28.2%; so far this year the figures are +33.5% and -30.3%.
Johnson & Johnson is the larger company by market value, about 326.0 times the size of Prestige Consumer Healthcare.
On trailing earnings, JNJ trades at 41.9 times and PBH at 13.3 times.
Revenue grew +7.8% at JNJ and +5.1% at PBH over the last year.
JNJ yields 1.91%. PBH pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| JNJ | PBH | |
|---|---|---|
| Price | $276.22 | $42.98 |
| 1-day | +1.43% | -3.02% |
| YTD | +33.47% | -30.33% |
| 1 year | +48.51% | -28.16% |
| 3 years | +85.77% | -27.78% |
| Market cap | $665.0B | $2.0B |
| P/E | 41.9 | 13.3 |
| P/S | 6.69 | 1.75 |
| P/B | 8.16 | 1.05 |
| Revenue growth | +7.80% | +5.10% |
| EPS growth | -36.40% | -19.80% |
| Gross margin % | 67.6 | 52.5 |
| Net margin % | 16.2 | 13.3 |
| ROE % | 19.7 | 8.0 |
| Debt / equity | 0.55 | 1.07 |
| FCF yield % | 3.1 | 10.5 |
| Dividend yield % | 1.91 | — |
| Beta | -0.09 | 0.45 |
| RSI (14) | 59.4 | 36.7 |
| Technical rating |